Literature DB >> 25886680

Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap.

Emmanuelle Levy1, Alexandru Traicu2, Srividya Iyer3, Ashok Malla4, Ridha Joober4.   

Abstract

Psychotic disorders (PDs) and attention-deficit hyperactivity disorder (ADHD) are frequently comorbid. Clinicians are often reticent to treat ADHD in patients with psychosis, fearing that psychostimulants will worsen psychotic symptoms. Advances in neurobiology have challenged the simplistic dichotomy where PD is considered a disorder of high dopamine (DA), treated by DA antagonists, and ADHD a disorder of low DA, treated by DA agonists. In our paper, we review the literature on comorbid ADHD and psychosis. Treating ADHD with psychostimulants may be considered in patients with PD who have been stabilized with antipsychotics (APs). Not treating ADHD may have consequences because ADHD may predispose patients to drug abuse, which further increases the risk of PD. Nevertheless, more systematic studies are needed as there remains some uncertainty on the combined use of APs and psychostimulants in comorbid PD and ADHD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25886680      PMCID: PMC4418622     

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  40 in total

Review 1.  ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.

Authors:  Scott H Kollins
Journal:  J Atten Disord       Date:  2008-01-11       Impact factor: 3.256

2.  Psychosis proneness and ADHD in young relatives of schizophrenia patients.

Authors:  Matcheri S Keshavan; Mandayam Sujata; Akhil Mehra; Debra M Montrose; John A Sweeney
Journal:  Schizophr Res       Date:  2003-01-01       Impact factor: 4.939

3.  Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.

Authors:  James J McGough; Susan L Smalley; James T McCracken; May Yang; Melissa Del'Homme; Deborah E Lynn; Sandra Loo
Journal:  Am J Psychiatry       Date:  2005-09       Impact factor: 18.112

Review 4.  Dopamine in schizophrenia: a review and reconceptualization.

Authors:  K L Davis; R S Kahn; G Ko; M Davidson
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

5.  Beyond words: how do children with ADHD and/or conduct problems process nonverbal information about affect?

Authors:  E B Cadesky; V L Mota; R J Schachar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-09       Impact factor: 8.829

6.  Characteristics of patients with schizophrenia successive to childhood attention deficit hyperactivity disorder (ADHD).

Authors:  I Elman; M Sigler; J Kronenberg; J P Lindenmayer; A Doron; S Mendlovic; B Gaoni
Journal:  Isr J Psychiatry Relat Sci       Date:  1998       Impact factor: 0.481

7.  Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia.

Authors:  T E Goldberg; L B Bigelow; D R Weinberger; D G Daniel; J E Kleinman
Journal:  Am J Psychiatry       Date:  1991-01       Impact factor: 18.112

Review 8.  Stimulus-dependent dopamine release in attention-deficit/hyperactivity disorder.

Authors:  Sverker Sikström; Göran Söderlund
Journal:  Psychol Rev       Date:  2007-10       Impact factor: 8.934

9.  Differentiating attention deficit in adult ADHD and schizophrenia.

Authors:  Jens Egeland
Journal:  Arch Clin Neuropsychol       Date:  2007-07-20       Impact factor: 2.813

Review 10.  The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.

Authors:  Timothy E Wilens
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

View more
  9 in total

1.  Characteristics of child psychiatric outpatients with slow processing speed and potential mechanisms of academic impact.

Authors:  Ellen B Braaten; Amanda K Ward; Gina Forchelli; Pieter J Vuijk; Nathan E Cook; Patrick McGuinness; B Andi Lee; Anna Samkavitz; Hannah Lind; Sheila M O'Keefe; Alysa E Doyle
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-01-24       Impact factor: 4.785

2.  The 10th Anniversary of the Eli Lilly Chair of Schizophrenia from the University of Montreal.

Authors:  Emmanuel Stip; Stéphane Potvin
Journal:  Can J Psychiatry       Date:  2015-03       Impact factor: 4.356

3.  Managing the comorbidity of schizophrenia and ADHD.

Authors:  Amy Gough; Jason Morrison
Journal:  J Psychiatry Neurosci       Date:  2016-08       Impact factor: 6.186

4.  Attention-deficit/hyperactivity disorder in youth with psychosis spectrum symptoms.

Authors:  Victoria Fox; Julia M Sheffield; Neil D Woodward
Journal:  Schizophr Res       Date:  2021-09-13       Impact factor: 4.939

5.  Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis.

Authors:  Mikaïl Nourredine; Adrien Gering; Pierre Fourneret; Benjamin Rolland; Bruno Falissard; Michel Cucherat; Marie-Maude Geoffray; Lucie Jurek
Journal:  JAMA Psychiatry       Date:  2021-05-01       Impact factor: 21.596

6.  Symptom Overlap and Screening for Symptoms of Attention-Deficit/Hyperactivity Disorder and Psychosis Risk in Help-Seeking Psychiatric Patients.

Authors:  Salvatore Corbisiero; Anita Riecher-Rössler; Jacqueline Buchli-Kammermann; Rolf-Dieter Stieglitz
Journal:  Front Psychiatry       Date:  2017-10-30       Impact factor: 4.157

Review 7.  Failures of cognitive control or attention? The case of stop-signal deficits in schizophrenia.

Authors:  Dora Matzke; Matthew Hughes; Johanna C Badcock; Patricia Michie; Andrew Heathcote
Journal:  Atten Percept Psychophys       Date:  2017-05       Impact factor: 2.199

8.  Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.

Authors:  Maria Niarchou; Samuel J R A Chawner; Ania Fiksinski; Jacob A S Vorstman; Johanna Maeder; Maude Schneider; Stephan Eliez; Marco Armando; Maria Pontillo; Stefano Vicari; Donna M McDonald-McGinn; Beverly S Emanuel; Elaine H Zackai; Carrie E Bearden; Vandana Shashi; Stephen R Hooper; Michael J Owen; Raquel E Gur; Naomi R Wray; Marianne B M van den Bree; Anita Thapar
Journal:  Schizophr Res       Date:  2018-08-07       Impact factor: 4.939

9.  Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea.

Authors:  Jeong-Cheol Seo; Duk-In Jon; Se-Hoon Shim; Hyung-Mo Sung; Young Sup Woo; Jeongwan Hong; Sung-Yong Park; Jeong Seok Seo; Won-Myong Bahk
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-02-28       Impact factor: 2.582

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.